IPO Analysis: IndiaMART IPO Analysis: IndiaMART IndiaMART, India's largest online B2B marketplace for business products and services, is entering the primary capital market with its initial public offering. Read on to find if you should subscribe the issue.
IPO Analysis: Neogen Chemicals IPO Analysis: Neogen Chemicals Neogen Chemicals (NCL), a Mumbai based company engaged into manufacturing of speciality chemicals is hitting the primary capital market to raise Rs 132.35 crore at uppper price band.
IPO Analysis: Polycab India Limited IPO Analysis: Polycab India Limited Polycab India (PIL), a Mumbai-based company is hitting the primary capital market with its initial public offering (IPO) of equity shares of Rs. 10 each. Read on to find if you should subscribe to the issue.
IPO Analysis: Metropolis Healthcare Limited IPO Analysis: Metropolis Healthcare Limited The Mumbai-based diagnostics company, Metropolis Healthcare Limited (MHL) is hitting the capital market with its maiden IPO. Read on to find should you subscribe to the issue.
IPO Analysis: RAIL VIKAS NIGAM LIMITED IPO Analysis: RAIL VIKAS NIGAM LIMITED The government-owned Rail Vikas Nigam Limited (RVNL), is entering the capital market with its IPO. Read on to find if you should subscribe to it.
Cipla receives final USFDA approval for Efavirenz Cipla receives final USFDA approval for Efavirenz Nikita Singh / 20-Jun-2018, 04:21 PM / Article rating: 4.3 Multinational pharma company, Cipla posted a 3 per cent hike in its share price as the company received final approval for its new drug application (ANDA) for Efavirenz tablets 600mg from the United States Food and Drug Administration (USFDA).
Alembic continues rally as Panelav unit receives EIR Alembic continues rally as Panelav unit receives EIR Nikita Singh / 15-Jun-2018, 12:36 PM / Article rating: 3.0 The share price of pharma major Alembic Pharmaceuticals continued to surge in Friday’s trading session. The share price grew by 7 per cent on Friday as the company bagged EIR for its formulation facility at Panelav, Gujarat from the US Food and Drugs Association.
Overnight Digest: Stocks to look out for on June 15 Overnight Digest: Stocks to look out for on June 15 Nikita Singh / 14-Jun-2018, 06:33 PM / Article rating: 5.0 The stocks that are likely to record significant movement on the bourses on Friday, June 15 are HIL Limited, Wipro Limited, Maha Rashtra Apex Corporation Limited and Hind Aluminium Industries Limited.
Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Nikita Singh / 14-Jun-2018, 12:52 PM / Article rating: 3.5 The share price of Cipla surged by nearly 2 per cent in the early trade on Thursday as the company received the USFDA approval for Isoproterenol Hydrochloride injection, a generic version of Hospira Inc’s Isuprel injection.
Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Nikita Singh / 14-Jun-2018, 12:29 PM / Article rating: 5.0 Pharma major Alembic Pharmaceuticals bagged the approval of US Food and Drugs Association for its abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules.